Scarica l'app Stockscreener
8.03
0.74%
-0.06
Precedente Chiudi:
$8.09
Aprire:
$8.25
Volume 24 ore:
1.14M
Relative Volume:
1.07
Capitalizzazione di mercato:
$551.13M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-3.7349
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
-14.21%
1M Prestazione:
-3.83%
6M Prestazione:
+57.45%
1 anno Prestazione:
-31.48%
Intervallo 1D:
$7.94
$8.33
Intervallo di 1 settimana:
$6.65
$8.48
Portata 52W:
$2.86
$13.51
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
8.03 | 555.25M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Has Olema Pharmaceuticals Inc. found a price floorPortfolio Gains Summary & Growth Focused Entry Point Reports - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Will Olema Pharmaceuticals Inc. continue its uptrendInflation Watch & Weekly Stock Breakout Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Olema Pharmaceuticals Inc. stock momentum explained2025 Fundamental Recap & Fast Gain Swing Trade Alerts - newser.com
Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Olema Pharmaceuticals Inc Stock Analysis and ForecastSector ETF Performance & Rapid Portfolio Trading - earlytimes.in
Can Olema Pharmaceuticals Inc. stock double in next 5 yearsEarnings Summary Report & Free Real-Time Volume Trigger Notifications - newser.com
Setup Watch: Will Olema Pharmaceuticals Inc. stock rally after Fed decisions2025 Stock Rankings & Low Risk High Reward Trade Ideas - nchmf.gov.vn
Olema Pharmaceuticals (OLMA) Stock Analysis: A 197.62% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Using flow based indicators on Olema Pharmaceuticals Inc.July 2025 Volume & Smart Allocation Stock Reports - newser.com
Visual trend scoring systems applied to Olema Pharmaceuticals Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 7.3%What's Next? - MarketBeat
Olema Pharmaceuticals: Tapping The Brakes (Rating Downgrade) (NASDAQ:OLMA) - Seeking Alpha
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Olema Pharmaceuticals Inc Azioni (OLMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.04 |
10,000 |
80,400 |
754,140 |
| Harmon Cyrus | Director |
Sep 18 '25 |
Sale |
8.32 |
3,086 |
25,676 |
117,028 |
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.08 |
1,914 |
15,465 |
120,114 |
1.11%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):